22 March 2021
Cenkos Securities plc
("Cenkos" or the "Company")
Director Shareholding
Cenkos was notified on 22 March 2021 that, on that same day, Lisa Gordon the Non-executive Chairman and Andrew Boorman a Non-executive Director purchased shares in the Company.
Lisa Gordon purchased 100,000 ordinary shares of 1p each in the Company ("Ordinary Shares") at 73.0 pence per Ordinary Share. Following this transaction, Lisa Gordon is interested in a total of 100,000 Ordinary Shares, representing 0.18% of the Company's issued ordinary share capital.
Andrew Boorman purchased a total of 20,000 Ordinary Shares of 1p each in the Company. This shares were purchased in two equal tranches of 10,000 Ordinary Shares at 71.9 pence and 73.0 pence per Ordinary Share, respectively. Following these transactions, Andy Boorman is interested in a total of 108,152 Ordinary Shares, representing 0.19% of the Company's issued ordinary share capital.
The notifications below, are made in accordance with the Market Abuse Regulation, provides further details in relation to the purchase of Ordinary Shares.
NOTIFICATIONS AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Lisa Gordon | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| PDMR (Non-Executive Chairman) | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| Cenkos Securities plc | |||
| b)
| LEI
| 213800ALVRC52VN3I821
| |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares of 1p each | |||
| | | ||||
| Identification code | GB00B1FLHR07 | ||||
| | | ||||
| b)
| Nature of the transaction
| Purchase of ordinary shares | |||
| c)
| Price(s) and volume(s) | | | | |
| | | Price(s) | Volume(s) | | |
| | | 73.00p | 100,000 |
| |
| | | | | | |
| d)
| Aggregated information | n/a - single transaction | |||
| | | ||||
| - Aggregated volume | | ||||
| | | ||||
| - Price | | ||||
| | | ||||
| e)
| Date of the transaction
| 22 March 2021 | |||
| f)
| Place of the transaction
| AIMX | |||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Andy Boorman | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| PDMR (Non-Executive Director) | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| Cenkos Securities plc | |||
| b)
| LEI
| 213800ALVRC52VN3I821
| |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares of 1p each | |||
| | | ||||
| Identification code | GB00B1FLHR07 | ||||
| | | ||||
| b)
| Nature of the transaction
| Purchase of ordinary shares | |||
| c)
| Price(s) and volume(s) | | | | |
| | | Price(s) | Volume(s) | | |
| | | 71.90p 73.00p | 10,000 10,000 |
| |
| | | | | | |
| d)
| Aggregated information | | |||
| | | ||||
| - Aggregated volume | 20,000 | ||||
| | | ||||
| - Total Price | £14,490 | ||||
| | | ||||
| e)
| Date of the transaction
| 22 March 2021 | |||
| f)
| Place of the transaction
| AIMX | |||
| For further information, please contact: | | ||||||||
| | | ||||||||
|
| ||||||||
| | | ||||||||
|
| |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
